NPI: 1992768329 · MONTCLAIR, CA 91763 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/07/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/07/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 24,176 | $1.85M |
| 2019 | 24,661 | $1.24M |
| 2020 | 21,144 | $1.05M |
| 2021 | 24,033 | $1.21M |
| 2022 | 19,528 | $1.06M |
| 2023 | 21,467 | $1.46M |
| 2024 | 12,132 | $1.48M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 53,842 | 4,718 | $8.82M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 43,320 | 3,222 | $313K |
| J1756 | Injection, iron sucrose, 1 mg | 11,127 | 2,840 | $89K |
| A4657 | Syringe, with or without needle, each | 4,296 | 1,916 | $85K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 842 | 434 | $35K |
| J1270 | Injection, doxercalciferol, 1 mcg | 22,883 | 1,994 | $9K |
| 82728 | 751 | 682 | $2K | |
| 83970 | 1,150 | 1,065 | $640.78 | |
| 90674 | 104 | 102 | $634.78 | |
| 90661 | 18 | 18 | $564.52 | |
| 83550 | 689 | 625 | $134.22 | |
| 83540 | 786 | 714 | $99.48 | |
| 85041 | 1,596 | 1,481 | $0.53 | |
| 85048 | 1,555 | 1,441 | $0.43 | |
| 0250 | 3,977 | 252 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 32 | 27 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 173 | 142 | $0.00 |